Vikram Deshpande - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Vikram Deshpande's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Vikram Deshpande
Verified
Editor-in-Chief, Journal of Clinical Pathology
Boston
Beats
farming,oceans, food, bacteria wellness, running, disease, fitness health, gut, octopus, medicine animals, psychology, nutrition, exercise science, brain, biology
Content
The future is now: advancing p53 immunohistochemistry in Barrett's oesophagus and its implication for the everyday pathologist
By Yevgen Chornenkyy, Monika Vyas, Vikram Deshpande Verified| Wiley Online Library Verified Conflicts of interest The authors declare no conflicts of interest. Supporting Information Filename Description his15442-sup-0001-TableS1.docxWord 2007 document , 131 KB Table S1. Summary of key studies evaluating the predictive value of p53 immunohistochemistry in Barrett's esophagus for progression. References 1, , et al. The utility of P53 immunohistochemistry in the diagnosis of barrett's oesophagus with indefinite for dysplasia. Histopathology 2022; 80; 1081–1090.
By Vikram Deshpande Verified, Munita Bal| Journal of Clinical Pathology Verified CARCINOMA Gastrointestinal Diseases Pathology Molecular In this issue of the Journal of Clinical Pathology, Pu and colleagues from the Nanjing University Medical School, China, report that NTRK gene alterations were enriched in gastric carcinoma with hepatoid or enteroblastic differentiation but not, as in the colon, dMMR-type gastric carcinomas.1 The study analysed 51 cases of EBV (Epstein-Barr virus)-associated gastric carcinomas, 94 cases of dMMR gastric carcinomas, 90 cases of gastric...
The future is now: advancing p53 immunohistochemistry in Barrett's oesophagus and its implication for the everyday pathologist
By Yevgen Chornenkyy, Monika Vyas, Vikram Deshpande Verified| Wiley Online Library Verified Conflicts of interest The authors declare no conflicts of interest. Supporting Information Filename Description his15442-sup-0001-TableS1.docxWord 2007 document , 131 KB Table S1. Summary of key studies evaluating the predictive value of p53 immunohistochemistry in Barrett's esophagus for progression. References 1, , et al. The utility of P53 immunohistochemistry in the diagnosis of barrett's oesophagus with indefinite for dysplasia. Histopathology 2022; 80; 1081–1090.
Company Info
Journal of Clinical Pathology
Boston, United States